Michael Ivanovich Sheremet
Overview
Explore the profile of Michael Ivanovich Sheremet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheremet M, Lazaruk O, Shidlovskyi O, Shidlovskyi V, Savin V, Olinik Y, et al.
J Med Life
. 2023 Mar;
16(1):35-41.
PMID: 36873136
Thyroid nodules are common, occurring in 50-60% of healthy patients. Currently, there are no effective conservative treatment options for nodular goiter, and surgery can have limitations and potential complications. The...
2.
Smolanka I, Movchan O, Bagmut I, Sheremet M, Kolisnyk I, Dosenko I, et al.
J Med Life
. 2023 Mar;
16(1):70-75.
PMID: 36873133
We aimed to analyze the frequency of breast cancer relapses and their relationship with molecular and biological tumor characteristics. We studied 6,136 breast cancer patients, including 146 with relapses (Group...
3.
Smolanka I, Galych S, Movchan O, Bagmut I, Sheremet M, Kolisnyk I, et al.
J Med Life
. 2023 Mar;
16(1):121-128.
PMID: 36873129
This study aimed to compare the results of free MS-TRAM and DIEP-flap based on the volume of the transplant and the unique characteristics of blood flow in the tissues. The...
4.
Smolanka I, Bagmut I, Movchan O, Sheremet M, Bilyi O, Lyashenko A, et al.
J Med Life
. 2023 Mar;
16(1):153-159.
PMID: 36873124
Expression of pro-malignant factors (VEGF) and cytokines like inflammatory components support breast cancer development. We examined 46 patients with stage IIIB inflammatory breast cancer (IBC) and 24 with stage IIA-IIIB...
5.
Dzyubanovsky I, Zaporozhets Y, Melnyk N, Pidruchna S, Dzyubanovsky O, Sheremet M
J Med Life
. 2023 Feb;
15(12):1548-1552.
PMID: 36762337
In recent years, there has been an unceasing increase in the number of patients with acute cholecystitis, including those with a complicated course of the disease against the background of...
6.
Movchan O, Bagmut I, Shipko A, Smolanka Senior I, Sheremet M, Kolisnyk I, et al.
J Med Life
. 2023 Feb;
15(12):1573-1578.
PMID: 36762329
This study aimed to investigate the impact of HER2-low on the risk of recurrence in individuals with inflammatory breast cancer (IBC). 60 females with HER2-low and HER2-positive IBC underwent surgery...
7.
Yuriivna T, Yevgenivich R, Sheremet M
J Med Life
. 2022 Dec;
15(11):1437-1441.
PMID: 36567828
This study assessed the effectiveness of a methodology aimed at developing prospective pharmacists' professionally oriented English lexical competence in reading and speaking during individual study. The methodology considered students' interests...
8.
Smolanka I, Bagmut I, Sheremet M, Movchan O, Oleksandrovich L, Smolanka Jr I, et al.
J Med Life
. 2022 Aug;
15(6):747-750.
PMID: 35928359
Energy and plastic potential dysfunction of erythrocytes and lymphocytes among people with inflammatory breast cancer, infiltrative stomach cancer, and infiltrative colon cancer is characterized by a more aggressive clinical course...
9.
Ditkivskyy I, Kravchenko V, Lohvinenko O, Sheremet M
J Med Life
. 2022 Apr;
15(2):222-227.
PMID: 35419099
The hybrid method of treating thoracic aortic pathology is devoid of the disadvantages of traditional open surgery and, at the same time, has a broader range of applications than the...
10.
Bagmut I, Ivanov O, Sheremet M, Smirnov S, Kolisnyk I, Ivanova J, et al.
J Med Life
. 2022 Feb;
15(1):65-70.
PMID: 35186138
This study investigates the response of bone marrow (particularly megakaryocytes) in mice under the influence of diclofenac sodium for 10 days using intraperitoneal injection at various doses. A fundamentally new...